(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI

Stopped The Data Monitoring Committee (DMC) concluded that the pre-specified futility threshold was met and that there was no safety concern.

Conditions

• Acute Kidney Injury Due to Sepsis

Interventions

• BIOLOGICAL: Recombinant human alkaline phosphatase
• OTHER: Placebo

Sponsor

AM-Pharma